|
Reglan/Metoclopromide Litigation |
|
|
|
|
On February 25, 2009, the FDA declared that companies selling metoclopromide-containing drugs, such as Reglan, must include a “Black Box” warning on the outer packaging of their product. This required warning states that prolonged or high-dose use of the drug metoclopromide, puts an individual at an increased risk of developing the disease Tardive Dyskinesia. Previously, companies selling products containing metoclopromide only included a small warning on the label of their product, listing Tardive Dyskinesia as a possible, but rare side effect.
Metoclopromide is a dopamine receptor antagonist, which stops the relaxation of stomach muscles. This, in turn, increases muscle contractions in the upper Gastrointestinal tract (GI tract). After all other treatment options have failed, metoclopromide is often prescribed to treat diabetic gastroparesis, gastroesophageal relux disease (GERD), nausea, vomiting, and persistent heart burn. Today, over two million people take metoclopromide, which can be a relatively safe and effective drug when taken in moderation. However, individuals taking large doses of metoclopromide or those taking the drug for more than 90 days are at high risk of developing Tardive Dyskinesia.
Tardive Dyskinesia is a life altering disease. It affects people physically, mentally, socially, emotionally, and vocationally. Symptoms include: puffing out of cheeks; puckering of the mouth; grimacing; chewing movements; smacking your lips; uncontrolled blinking; and other involuntary, repetitive, tic-like movements of the facial muscles, finger, limbs, or torso. Once Tardive Dyskinesia is acquired, it is rarely reversible. Occasionally, symptoms lessen after a person has stopped taking metoclopromide; however, most individuals continue to feel the full effects of the disease for the rest of their lives.
If you or a loved one has Tardive Dyskinesia due to metoclopromide-containing drugs, please contact the law firm of Babbitt, Johnson, Osborne, & Leclainche as soon as possible for your free consultation and client review. The harm metoclopromide-containing drugs have caused, due to improper warnings, should not go unanswered. Babbitt, Johnson, Osborne, & Leclainche has been litigating some of the most complicated pharmaceutical matters to be seen in the State of Florida for the last four decades. Babbitt, Johnson, Osborne & Leclainche doesn’t just seek compensation; It seeks accountability. And most importantly, for the last 40 years, it’s been getting it.
|
